>
pdufa.bio

NBTXR3

Updated ยทnext FDA decision on the calendar

NBTXR3 is a Nanobiotix S.A. program. Its next catalyst is a Readout in Apr 2027. Every date links its source.

NBTX catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Nanobiotix S.A. (NBTX). We track 1 catalyst event for this program: 1 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Apr 2027NBTX

Questions

When is NBTXR3's next FDA decision or readout?

The next tracked catalyst for NBTXR3 is a Readout in Apr 2027.

What happened at NBTXR3's most recent FDA decision?

No FDA decision for NBTXR3 is in our archive yet.

Who makes NBTXR3?

Nanobiotix S.A. (NBTX).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.